Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for 532 Patients with KMT2A-Rearranged Acute Leukemia

Ruijuan Sun, Yue Lu, Jian-Ping Zhang, Jiarui Zhou, Deyan Liu, Yanli Zhao, Zhijie Wei, Min Xiong, Xingyu Cao, Peihua Lu

Blood (2024) 144 (Supplement 1): 3546.

https://doi.org/10.1182/blood-2024-206907

Published: 2024

Journal Articles

A Long-Term Follow-up Retrospective Study of the Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation for Early T-Precursor Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Xingyu Cao, Yue Lu, Jian-Ping Zhang, Deyan Liu, Zhijie Wei, Yanli Zhao, Jiarui Zhou, Min Xiong, Ruijuan Sun, Jing Long, Peihua Lu

Blood (2024) 144 (Supplement 1): 4934.

https://doi.org/10.1182/blood-2024-204579

Published: 2024

Journal Articles

The Role of Metagenomics Next-Generation Sequencing (mNGS) in Early Diagnosis of Bloodstream Infection in Hematologic Patients with Febrile Neutropenia: A Multicenter Prospective Study

Yu-Qian Sun, Jing-Rui Zhou, Yue Yin, Jian-Ping Zhang, Mei-Xiang Zhang, Yun He, Xiao-Jun Huang

Blood (2022) 140 (Supplement 1): 4984–4985.

https://doi.org/10.1182/blood-2022-165036

Published: 2022

Journal Articles

Analysis Benefits of a Second Allo-HSCT after CAR-T Cell Therapy in 97 Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Who Relapsed after a First Transplant

Xing-yu Cao, Jian-Ping Zhang, Yan-Li Zhao, Min Xiong, Jiarui Zhou, Yue Lu, Ruijuan Sun, Zhijie Wei, Deyan Liu, Xian Zhang, Junfang Yang, Peihua Lu

Blood (2022) 140 (Supplement 1): 4802–4803.

https://doi.org/10.1182/blood-2022-166993

Published: 2022

Journal Articles

Modeling acute erythroid leukemia via CRISPR

Jian-Ping Zhang, Tao Cheng

Blood (2021) 137 (12): 1565–1567.

https://doi.org/10.1182/blood.2020010544

Published: 2021

Journal Articles

Clinical Features and Outcome of 22 Leukemia Patients with TLS-ERG Fusion Gene

Jing Pan, MD, Tong Wu, MD, Jun-Fang Yang, MD, Jian-Ping Zhang, Yan-Li Zhao, Yang Zhang, MD, Hong-Xing Liu, MD, Chun-Rong Tong, MD

Blood (2016) 128 (22): 3985.

https://doi.org/10.1182/blood.V128.22.3985.3985

Published: 2016

Journal Articles

Immunotherapy with Autologous Anti-CD19 Chimeric Antigen Receptor T Cells Followed By Allogeneic Hematopoietic Stem Cell Transplantation Has Remarkably Improved Leukemia-Free Survival in Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia

Yan-Li Zhao, MD, Tong Wu, MD, De-Yan Liu, Jian-Ping Zhang, Zhi-Jie Wei, Yue Lu, Xing-Yu Cao, Min Xiong, Jia-Rui Zhou, Rui-Juan Sun, Shu-Quan Ji, Chun-Rong Tong, Dao-Pei Lu

Blood (2016) 128 (22): 829.

https://doi.org/10.1182/blood.V128.22.829.829

Published: 2016

Journal Articles

Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study

Lung-Ji Chang, PhD, Lujia Dong, MD, Yu-Chen Liu, MSc, Shih-Ting Tsao, MSc, Ya-Chen Li, PhD, Li Liu, MD, Zhiyong Gao, MD, Xiyou Tan, MD, Dao-Pei Lu, MD, Jian-Ping Zhang, Jing-Bo Wang, Yu-Ming Ying, MD, Le-Ping Zhang, MD, Huyong Zheng, MD PhD, Kai Wang, MD PhD, Xiao-Li Zheng, MD, Heng-Xiang Wang, MD, Xun Lai, MD, Dong Li, MD

Blood (2016) 128 (22): 587.

https://doi.org/10.1182/blood.V128.22.587.587

Published: 2016

Journal Articles

Impact of NCCN Risk Stratification and Minimal Residual Disease on Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Yue Lu, Tong Wu, MD, Yan-Li Zhao, Xing-Yu Cao, De-Yan Liu, Jian-Ping Zhang, Min Xiong, Jia-Rui Zhou, Rui-Juan Sun, Zhi-Jie Wei, Hui Wang, Tong Wang, Hong-Xing Liu, Dao-Pei Lu

Blood (2016) 128 (22): 2296.

https://doi.org/10.1182/blood.V128.22.2296.2296

Published: 2016

Journal Articles

Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China

Lujia Dong, MD, Lung-Ji Chang, PhD, Zhiyong Gao, MD, Dao-Pei Lu, MD, Jian-Ping Zhang, MD, Jing-Bo Wang, MD, Le-Ping Zhang, MD, Yu-Hong Chen, MD, Hu-Yong Zheng, MD, Ting Liu, Ting Niu, MD PhD, He Huang, MD PhD, Rong Liu, MD, Heng-Xiang Wang, MD, Li Gao, MD, Tong-Hua Yang, MD, Xun Lai, MD

Blood (2015) 126 (23): 3774.

https://doi.org/10.1182/blood.V126.23.3774.3774

Published: 2015

Journal Articles

Impact of Cytogenetic and Molecular Markers on Disease-Free Survival of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Yue Lu, Tong Wu, Xing-Yu Cao, Yan-Li Zhao, De-Yan Liu, Min Xiong, Jian-Ping Zhang, Rui-Juan Sun, Zhi-Jie Wei, Jia-Rui Zhou, Hong-Xing Liu, Tong Wang, Shu-Quan Ji, Dao-Pei Lu

Blood (2015) 126 (23): 3217.

https://doi.org/10.1182/blood.V126.23.3217.3217

Published: 2015

Journal Articles

Improved Outcomes of Haploidentical Blood and Marrow Transplantation in Hematologic Malignancies: A Single Center Study of 514 Cases

Yan-Li Zhao, Tong Wu, Yue Lu, Xing-Yu Cao, De-Yan Liu, Min Xiong, Jian-Ping Zhang, Zhi-Jie Wei, Jia-Rui Zhou, Rui-Juan Sun, Chun-Rong Tong, Hong-Xing Liu, Hui Wang, Tong Wang, Shu-Quan Ji, Dao-Pei Lu

Blood (2015) 126 (23): 3224.

https://doi.org/10.1182/blood.V126.23.3224.3224

Published: 2015

Journal Articles

Donor-Derived Ex-Vivo Activated NK Cells in Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Acute Leukemia

Xing-Yu Cao, Tong Wu, Bi-Ping Deng, Rui-Juan Sun, Yue Lu, Yan-Li Zhao, Jian-Ping Zhang, Jia-Rui Zhou, Zhi-Jie Wei, Xiu-Yan Tao, Hui Wang, Hong-Xing Liu, Dao-Pei Lu, Chun-Rong Tong

Blood (2014) 124 (21): 312.

https://doi.org/10.1182/blood.V124.21.312.312

Published: 2014

Journal Articles

Improved Outcomes of Haploidentical Blood and Marrow Transplantation with Giac-3 Protocol That Haploidentical Bone Marrow from the Second Donor As the Third Party Cells

Yan-Li Zhao, Tong Wu, Yue Lu, Xing-Yu Cao, De-Yan Liu, Min Xiong, Zhi-Jie Wei, Jian-Ping Zhang, Jia-Rui Zhou, Rui-Juan Sun, Shu-Quan Ji, Dao-Pei Lu

Blood (2014) 124 (21): 1214.

https://doi.org/10.1182/blood.V124.21.1214.1214

Published: 2014

Journal Articles

Disease-Free Survival Of Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Is Not Associated With Disease Status and Donor Sources

Yue Lu, Tong Wu, Xing-Yu Cao, Yan-Li Zhao, De-Yan Liu, Jia-Rui Zhou, Min Xiong, Jian-Ping Zhang, Rui-Juan Sun, Zhi-Jie Wei, Shu-Quan Ji, Dao-Pei Lu

Blood (2013) 122 (21): 2158.

https://doi.org/10.1182/blood.V122.21.2158.2158

Published: 2013

Journal Articles

Management of Early Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation by Donor’s Dendritic Cell-Primed Cytokine- Induced Killer Cells

Jing-Bo Wang, Tong Wu, Jun-Fang Yang, Jian-Ping Zhang, Xing-Yu Cao, Yu-Ming Yin, Yuan Sun, Rong-Mu Luo, Dao-Pei Lu, Chun-Rong Tong

Blood (2008) 112 (11): 829.

https://doi.org/10.1182/blood.V112.11.829.829

Published: 2008

NARROW

Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for 532 Patients with KMT2A-Rearranged Acute Leukemia

A Long-Term Follow-up Retrospective Study of the Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation for Early T-Precursor Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

The Role of Metagenomics Next-Generation Sequencing (mNGS) in Early Diagnosis of Bloodstream Infection in Hematologic Patients with Febrile Neutropenia: A Multicenter Prospective Study

Analysis Benefits of a Second Allo-HSCT after CAR-T Cell Therapy in 97 Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Who Relapsed after a First Transplant

Modeling acute erythroid leukemia via CRISPR

Clinical Features and Outcome of 22 Leukemia Patients with TLS-ERG Fusion Gene

Immunotherapy with Autologous Anti-CD19 Chimeric Antigen Receptor T Cells Followed By Allogeneic Hematopoietic Stem Cell Transplantation Has Remarkably Improved Leukemia-Free Survival in Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia

Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study

Impact of NCCN Risk Stratification and Minimal Residual Disease on Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China

Impact of Cytogenetic and Molecular Markers on Disease-Free Survival of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Improved Outcomes of Haploidentical Blood and Marrow Transplantation in Hematologic Malignancies: A Single Center Study of 514 Cases

Donor-Derived Ex-Vivo Activated NK Cells in Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Acute Leukemia

Improved Outcomes of Haploidentical Blood and Marrow Transplantation with Giac-3 Protocol That Haploidentical Bone Marrow from the Second Donor As the Third Party Cells

Disease-Free Survival Of Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Is Not Associated With Disease Status and Donor Sources

Management of Early Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation by Donor’s Dendritic Cell-Primed Cytokine- Induced Killer Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only